Extended Care Treatment of Multiple Risk Behaviors in Complex Patients
Extended Care Treatment of Multiple Risk Behaviors in Complex Patients
批准号:
8376913
负责人:
JOSEPH R GUYDISH
金额:
$23.94万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2015-05-31
关键词:
AddressAgeAlcohol abuseAlcohol dependenceAlcohol or Other Drugs useAlcoholsBehaviorBehavioralBuprenorphineClientClinicCocaineColorectalComorbidityComplexComputersCountyDataDiagnosisDietDimensionsDistressDrug AddictionDrug abuseDrug usageEducationEthnic OriginFeedbackGenderHealthHealth BenefitHealth Care CostsHealth PlanningHealth PromotionHealth behaviorHygieneIllicit DrugsIndividualInpatientsInterventionLeftLong-Term CareMammographyManaged CareMarijuanaMeasuresMedicalMedical centerMental DepressionMental HealthModelingMorbidity - disease rateMotivationOpiate AddictionOpiatesOutcomeParticipantPatientsPharmaceutical PreparationsPhasePhysical activityPilot ProjectsPremature MortalityPrevalenceProfessional counselorPublic HealthRandomizedReadinessRecommendationRelative (related person)ReportingResearchRiskRisk AssessmentRisk BehaviorsRisk FactorsSamplingScreening for cancerServicesSeveritiesSleepSocioeconomic StatusStagingStressTimeTobaccoTobacco useVeteransWorkplaceaddictionalcohol and other drugbasebehavior changecare systemscostdesignfollow-upfruits and vegetablesgood diethealth related quality of lifeindexinginnovationmedication compliancemotivational enhancement therapyphysical conditioningpreferencestress managementtreatment as usual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The theme of this Center, continuing and extended care models for drug abuse treatment, affords greater
opportunity to address the broader health needs of patients over time. Risk behaviors tend to co-occur, and
people who abuse alcohol or other drugs are likely to carry additional risks, such as tobacco use, poor diet,
physical inactivity, stress and distress, and poor sleep quality. Targeting change in multiple risks offers the
potential of increased health benefits, maximized health promotion, and reduced medical costs. Yet, controversies
remain regarding how to, and even whether to, assess and treat the multiple comorbid conditions
with which patients present. Proceeding in two phases, this Integrative component will provide unique
information on the multiple behavioral risks, health functioning, and comprehensive treatment needs of 1200
clients in drug abuse treatment in three very different systems of care: a county public health buprenorphine
clinic, a large non-profit integrated managed care health plan, and a Veteran's Affairs medical center.
In Phase I, 900 participants from Drs. Hall's and Weisner's components will complete a health risk
assessment of 16 behaviors that also assesses participants' stage of change. The primary aims are to
examine: the prevalence of multiple risk behaviors and motivation to change among individuals in drug
treatment; the association between multiple risk behaviors and health-related quality of life; covariation in
changes in risk behaviors; and the medical costs associated with multiple risks and changes over 18-months
time. Findings will identify treatment needs and prioritize intervention targets for the pilot study in Phase II.
Phase II pilots and evaluates, in a randomized controlled thai, an Innovative, online, extended-care,
computer-delivered and stage-tailored health risk intervention (S-HRI) with 300 participants in drug abuse
treatment. The S-HRI provides feedback on participants' stages of change for each risk with
recommendations on the single most important step they can take to begin progressing. A counselor will
review the report with participants and provide motivational interviewing (Ml) coaching and referrals to
relevant behavior change services. Intervention participants will complete the S-HRI and Ml-coaching
sessions at baseline, 3, 6 and 12 months follow-up. Primary hypotheses are that, relative to usual care, the
Intervention will result in greater: (1) client engagement with behavior change service referrals, (2) behavioral
changes in multiple risks, and (3) improvements In health-related quality of life at 3, 6, 12, and 18 months
follow-up. A secondary aim will examine retention In addictions treatment by condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: